Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non–Small Cell Lung Cancer()

BACKGROUND: Efficacy of second-line chemotherapy in platinum-pretreated non–small cell lung cancer (NSCLC) is poor. This study investigated efficacy of computed tomography–guided percutaneous fine-needle 5% ethanol-cisplatin intratumoral injection (CT-PFNECII) combined with second-line chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Qi, Wang, Wei, Li, Qian, Li, Yong, Ruden, Douglas M., He, Baoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101294/
https://www.ncbi.nlm.nih.gov/pubmed/24726235
http://dx.doi.org/10.1016/j.tranon.2014.02.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101294/
https://www.ncbi.nlm.nih.gov/pubmed/24726235
http://dx.doi.org/10.1016/j.tranon.2014.02.017

Ejemplares similares